Watch Ticker

Madrigal Pharmaceuticals, Inc. Common Stock

Go to Madrigal Pharmaceuticals, Inc. Common Stock Website

$302.17

-0.34 (-0.11%)

Live

Previous Close

$302.17

Day Range

$298 - $308.52

Previous Day Range

$290 - $312.05

Market Cap

$6.7 billion USD

Day Vol.

236802

Previous Day Vol.

535496

Currency

USD

Primary Exchange

Nasdaq

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver f...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Madrigal Pharmaceuticals - Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025

Madrigal Pharmaceuticals will release its Q2 2025 financial results on August 5, 2025, and host a live webcast at 8 a.m. Eastern Time to review financial and operating results.

Related tickers: MDGL, OBDC.

Read Full Article

N/A - Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis

Madrigal Pharmaceuticals announced positive two-year results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of Rezdiffra, demonstrating significant improvements in liver stiffness, liver fat, fibrosis biomarkers, liver volume, and risk scores for clinically significant portal hypertension.

Related tickers: MDGL.

Read Full Article

Trending Tickers

Please sign in to view